COFACECOFA
COFA logo
Fair Value
€18.63
Share price10 Jul
€15.8714.8% undervalued intrinsic discount
Loading
1Y-4.91%
7D-0.63%

Strong Solvency Ratio Will Support Acquisitions And Organic Expansion

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
15 Feb 25
Updated
10 Jul 26
Views
166
Not Invested

Last Update 10 Jul 26

Fair value Increased 5.11%

COFA: Future Returns Will Rely On Dividend Policy And Higher Earnings Multiple

Analysts have revised their price target on COFACE, lifting fair value from €17.72 to €18.63, with updated assumptions that include adjusted discount rates, revenue growth expectations, profit margin outlook, and a new forward P/E input.

What’s in the News for COFACE

  • COFACE SA shareholders approved a dividend of €1.25 per share for the 2025 financial year at the combined shareholder meeting held on May 19, 2026, with payment scheduled for May 28, 2026, and an ex-dividend date of May 26, 2026. (Source: Key Developments)
  • COFACE SA held a board meeting on May 12, 2026, to discuss the consolidated financial statements as of March 31, 2026. (Source: Key Developments)

Valuation Changes for COFACE

  • Fair Value was raised from €17.72 to €18.63 per share, indicating a modest upward adjustment in the valuation model.
  • The Discount Rate moved slightly higher from 7.73% to about 7.97%, reflecting a marginally higher required return in the updated assumptions.
  • Revenue Growth was adjusted from 3.13% to about 4.45%, pointing to higher expected € revenue expansion in the forecast period.
  • The Net Profit Margin was revised from about 12.86% to about 12.16%, implying slightly lower expected profitability on future € earnings.
  • Future P/E increased from about 12.0x to about 13.9x, suggesting that COFACE is now being valued on a higher earnings multiple in the updated model.
6 viewsusers have viewed this narrative update

Key Takeaways

  • Acquisitions and tech investments may enhance efficiencies and profitability, boosting revenue streams and long-term growth potential.
  • Strong client retention and financial solvency support consistent revenue and expansion opportunities through acquisitions and organic growth.
  • Economic volatility, rising insolvencies, and competitive pressures in insurance pose risks to profitability and consistent revenue growth for COFACE.

Catalysts

About COFACE
    Through its subsidiaries, provides credit insurance products and related services for microenterprises, small and medium enterprises, mid-market companies, international corporations, financial institutions, and clients of distribution partners.
What are the underlying business or industry changes driving this perspective?
  • The acquisition of Cedar Rose, a key information provider in the Middle East, is expected to enhance COFACE's information services capabilities, potentially boosting future revenue streams.
  • The continued investment in COFACE's business information (BI) venture and growth in the debt collection segment, both growing at double digits, indicate potential future earnings growth as these ventures scale.
  • The company's high client retention rate of 92.3% and selective growth strategy are likely to stabilize and potentially increase revenue, contributing to consistent revenue streams.
  • The deliberate investment in technology and data is expected to drive efficiencies and improve net margins over time, enhancing the overall profitability of the company.
  • COFACE's strong solvency ratio (196%), above the target range, provides a solid foundation for future growth activities, such as acquisitions and organic expansion, which can lead to increased earnings.
COFACE Earnings and Revenue Growth

COFACE Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming COFACE's revenue will grow by 4.5% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 11.7% today to 12.2% in 3 years time.
  • Analysts expect earnings to reach €252.8 million (and earnings per share of €1.7) by about July 2029, up from €213.5 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €293.8 million in earnings, and the most bearish expecting €219.1 million.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.9x on those 2029 earnings, up from 11.0x today. This future PE is greater than the current PE for the GB Insurance industry at 11.6x.
  • Analysts expect the number of shares outstanding to grow by 0.12% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.97%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The company's total revenues are slightly down from 2023 at -0.6%, with insurance revenue specifically down 2.2%, potentially impacting the overall revenue and net margins.
  • The combined ratio has increased by 1.2 points, driven by a 3.6% increase in the cost ratio, which suggests ongoing cost pressures and investments that could impact net earnings.
  • The high rate of insolvencies, with numbers 20-30% higher than 2019, presents a risk to maintain profitability and manage claims, potentially affecting net margins.
  • Market volatility and slowing economies, particularly in Europe, add uncertainty that may prevent consistent revenue growth and affect net income.
  • Factoring and trade credit insurance businesses are facing competitive pressures and pricing declines, with a price effect at -1.4%, which could challenge future revenue generation and profit margins.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €18.62 for COFACE based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €22.5, and the most bearish reporting a price target of just €17.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €2.1 billion, earnings will come to €252.8 million, and it would be trading on a PE ratio of 13.9x, assuming you use a discount rate of 8.0%.
  • Given the current share price of €15.7, the analyst price target of €18.62 is 15.7% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on COFACE?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

€18.63
vs €15.8714.8% undervalued intrinsic discount
PastFuture02b2015201820212024202620272029Revenue €2.1bEarnings €252.8m
4.5%
Revenue growth
12.2%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on COFACE

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Good value with mediocre balance sheet.

Market cap€2.4b
PB1.1x
Estimated Growth4.2%
Dividend Yield7.9%
Full analysis

CEO & management

Xavier Durand
CEO
9.3yrs
CEO Tenure

Through its subsidiaries, provides trade credit insurance products and services for small and medium enterprises, mid-market companies, international corporations, international companies, financial institutions, and clients of distribution partners.